Browse Categories

Publications by authors named "Murray Barron"

  • Page 1 of 1
Health Care Utilization: What Is the Cost of Caring for Scleroderma?
Kathleen Morrisroe Nora Sandorfi Murray Barron

Rheum Dis Clin North Am

May 2023

Systemic sclerosis (SSc), also known as scleroderma, is a chronic autoimmune connective tissue disease and is associated with a significant economic burden resulting from health care utilization costs in addition to indirect costs attributable to SSc resulting from early retirement and lost productivity in those that remain in employment.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Murray Barron"

  • - Murray Barron's recent research focuses on the economic implications of systemic sclerosis (scleroderma), specifically examining health care utilization costs associated with the disease.
  • - In his 2023 article, he highlights the substantial financial burden of scleroderma, which includes both direct health care expenses and indirect costs related to early retirement and diminished productivity among affected individuals.
  • - The findings emphasize the need for a better understanding of the economic impact of chronic diseases like scleroderma, suggesting potential areas for policy development and targeted support for affected patients.

Privacy Policy Site Map

© LitMetric 2025. All rights reserved.